Kaleido Biosciences Inc
Biotechnology
Healthcare
KLDO
42.58M shares
NASDAQ US
traded
07 Apr 2022
listed
yes
open
1.50
52 week high
8.72
high
1.59
52 week low
1.32
previous Close
1.49
P/E ratio
-3
market cap
63.51M
div yield
0
net incoming
-20.27M
12.19 %
net profit margin
-4120.33 %
18076.00 %
operating incoming
-19.70M
12.11 %
net change in cash
-17.18M
-5.28 %
cash on hand
38.47M
-30.87 %
top